📰 **Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance **

Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform.

🔗 https://www.cnbc.com/2026/05/12/hims-hers-plummets-16percent-after-first-quarter-loss-weak-guidance-.html

#markets #news